several studies in volunteers with short and long-acting bd used as sedatives and hypnotics including diazepam ( dzp ) , flunitrazepam ( fnz ) , flurazepam ( fzp ) , lormetazepam ( lmz ) , oxazepam , temazepam and triazolam indicate that pharmacokinetic data ( e.g . elimination half-lives of receptor active compounds ) concur with the results obtained from other methods , if active metabolites are taken into account .
C0005064
bd
C0029997
oxazepam